TITLE

Recommendations for Management of the Trastuzumab (Herceptin) among Iranian Breast Cancer Patients, a Policy Brief

AUTHOR(S)
Rouhollahi, Mohammad Reza; Samad Mohammad Nejad; Harirchi, Iraj; Zarei, Behrouz; Keshtmand, Glavizh; Sedighi, Sanambar; Amanpour, Saeid; Abdirad, Afshin; Kokhaei, Parviz; Aghili, Mehdi; Hashemi, Farnaz Amoozegar; Rajabpour, Mojtaba Vand; Zendehdel, Kazem
PUB. DATE
May 2014
SOURCE
Basic & Clinical Cancer Research;May2014, Vol. 6 Issue 2, p27
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Allocation of the new (expensive) drugs for difficult refractory diseases and financial protection of the patients is an important challenge in the national health systems worldwide especially in developing countries. Trastuzumab (Herceptin) as one of the effective but expensive drugs, put major financial burden for the Iranian patients and government. So the Ministry of Health and Medical Education (MOHME), decided to implement a national program for appropriate management of breast cancer and regulation of Trastuzumab in I.R of Iran (NPMBCT). In this policy brief we evaluated this issue and provided necessary recommendations. Methods: We designed a conceptual model consisting of the goals, main and supporting processes for management of Trastuzumab in the national program. Five macro-processes selected as the main concerns. Then an expert panel including different scientific disciplines discussed the different aspects of the issue and provided the necessary recommendations. We determined the link between the suggested recommendations and the objectives of the program. Results: Based on the five selected main processes, the experts provided 10 recommendations including: 1) balance in the resource allocation, 2) appropriate modeling for the subsides allocation, 3) avoiding "poor subsidize the rich" phenomenon, 4) development and updating the clinical guidelines, 5) cost-effectiveness analysis on accepted guideline, 6) Quality improvement of diagnostic tests, 7) standardization of the laboratory kits, 8) brand management and lowering the drug cost, 9) improving the patient registry system by ICT infra-structure, 10) development of expert systems to empower the diagnostic laboratories. Conclusion: Given these recommendations, the NPMBCT program will be a successful model for the appropriate management of the expensive drugs and treatment of breast cancer in I.R. of Iran and other developing countries.
ACCESSION #
111380083

 

Related Articles

  • A Brief Intervention Designed to Increase Breast Cancer Self-Screening. Lindberg, Nangel M.; Stevens, Victor J.; Smith, K. Sabina; Glasgow, Russell E.; Toobert, Deborah J. // American Journal of Health Promotion;May/Jun2009, Vol. 23 Issue 5, p320 

    Purpose. To assess the efficacy of an intervention designed to increase appropriate use of breast self-examination (BSE). Methods. Two-armed randomized clinical trial of cancer-control interventions in women that compared a BSE intervention program to a dietary intervention, which served as the...

  • SCHOOL BRIEFS.  // Hays Free Press (Buda, TX);8/6/2008, Vol. 105 Issue 18, p3B 

    The article offers news briefs related to health services in Texas, which include a three-day clinic sponsored by Hays High School's varsity cheer coach Shelley Plumley, services offered by an Austin non-profit agency, and the funding grant received by the Kyle Elementary Environmental Study Center.

  • Opinion: Inside Commissioning - The latest thinking on redesigning healthcare.  // GP: General Practitioner;10/24/2012, p25 

    The article reports on the latest thinking on redesigning healthcare.

  • For the best outcomes, consider patients' culture.  // Patient Education Management;Oct2009, Vol. 16 Issue 10, p116 

    The article discusses the importance of cultural competency to the success of patient care and treatment plan.

  • Integration new normal for Canty. Tophain-Kindley, Liane // New Zealand Doctor;1/30/2013, p13 

    The article reports on the applicability of the concept integrated family health centre, which include the New Zealand healthcare provider Pegasus.

  • Interventional Cardiology.  // Medical Economics;4/3/2009, Vol. 86 Issue 7, p31 

    The article provides information about the development of interventional cardiological centers in the U.S. Intervention centers in the country have become successful in providing cardiology treatments, research development and patient care, as well as recognized as clinical centers of...

  • New research shows the value of Rx interventions.  // Chain Drug Review;4/18/2016, Vol. 38 Issue 7, p1 

    The article presents a study from American holding company Walgreens Boots Alliance Inc. which reveals the key role of pharmacy interventions in leading to greater medication adherence and lower health care costs.

  • Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer. Pharoah, Paul D.P.; Antoniou, Antonis C.; Easton, Douglas F.; Ponder, Bruce A.J. // New England Journal of Medicine;6/26/2008, Vol. 358 Issue 26, p2796 

    Background: New developments in the search for susceptibility alleles in complex disorders provide support for the possibility of a polygenic approach to the prevention and treatment of common diseases. Methods: We examined the implications, both for individualized disease prevention and for...

  • Estratégias de enfrentamento do câncer de mama: um estudo de caso com famílias de mulheres mastectomizadas. Tavares, Jeane Saskya Campos; Trad, Leny Alves Bomfim // Revista Ciência & Saúde Coletiva;2010, Vol. 15 Issue S1, p1349 

    This study sought to analyze strategies for coping with the disease and the implications of breast cancer for the affected families. Semistructured interviews and observations were conducted in households with 5 families of women diagnosed with breast cancer in various stages of development and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics